Trials / Active Not Recruiting
Active Not RecruitingNCT06621316
A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects
To Explore the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Multiple Doses of HRS-7535 in Obese Subjects
- Status
- Active Not Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Shandong Suncadia Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of HRS-7535 tablet in obese subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-7535 Tablet | at multiple dose levels |
| DRUG | Placebo | at multiple dose levels (matching active arm HRS-7535 Tablet) |
Timeline
- Start date
- 2024-10-30
- Primary completion
- 2025-05-30
- Completion
- 2025-06-30
- First posted
- 2024-10-01
- Last updated
- 2025-04-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06621316. Inclusion in this directory is not an endorsement.